Search Results - "Bittenglová, Radka"

EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis by Doubková, Martina, Švancara, Jan, Svoboda, Michal, Šterclová, Martina, Bartoš, Vladimír, Plačková, Martina, Lacina, Ladislav, Žurková, Monika, Binková, Ilona, Bittenglová, Radka, Lošťáková, Vladimíra, Merta, Zdeněk, Šišková, Lenka, Tyl, Richard, Lisá, Pavlína, Šuldová, Hana, Petřík, František, Pšikalová, Jana, Řihák, Vladimír, Snížek, Tomáš, Reiterer, Pavel, Homolka, Jiří, Musilová, Pavlína, Lněnička, Jaroslav, Palúch, Peter, Hrdina, Roman, Králová, Renata, Hortvíková, Hana, Strenková, Jana, Vašáková, Martina

“…Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the…”
Get more information

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis by Tran, Tanja, Šterclová, Martina, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Müller, Veronika, Hájková, Marta, Kramer, Mordechai R, Jovanović, Dragana, Tekavec-Trkanjec, Jasna, Studnicka, Michael, Stoeva, Natalia, Hejduk, Karel, Dušek, Ladislav, Suissa, Samy, Vašáková, Martina

“…Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of…”
Get full text

The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry by Štefániková, Marianna, Doubková, Martina, Ovesná, Petra, Šterclová, Martina, Lacina, Ladislav, Žurková, Monika, Plačková, Martina, Bartoš, Vladimír, Janíčková, Ivana, Bittenglová, Radka, Anton, Jan, Sýkorová, Ľubica, Lošťáková, Vladimíra, Musilová, Pavlína, Šuldová, Hana, Mokošová, Radka, Didyk, Jurij, Šišáková, Lenka, Lisá, Pavlína, Lněnička, Jaroslav, Dařičková, Hana, Doležel, Daniel, Pšikalová, Jana, Tyl, Richard, Králová, Renata, Vašáková, Martina Koziar

“…The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic…”
Get full text

Age-Related Progression of Microvascular Dysfunction in Cystic Fibrosis: New Detection Ways and Clinical Outcomes by Kreslová, M, Sýkorová, A, Bittenglová, R, Schwarz, J, Pomahačová, R, Jehlička, P, Kobr, J, Trefil, L, Sýkora, J

“…There are concerns about altered vascular functions that could play an important role in the pathogenesis and influence the severity of chronic disease,…”
Get full text

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry by Zurkova, Monika, Kriegova, Eva, Kolek, Vitezslav, Lostakova, Vladimira, Sterclova, Martina, Bartos, Vladimir, Doubkova, Martina, Binkova, Ilona, Svoboda, Michal, Strenkova, Jana, Janotova, Marketa, Plackova, Martina, Lacina, Ladislav, Rihak, Vladimir, Petrik, Frantisek, Lisa, Pavlina, Bittenglova, Radka, Tyl, Richard, Ondrejka, Gustav, Suldova, Hana, Lnenicka, Jaroslav, Psikalova, Jana, Snizek, Tomas, Homolka, Jiri, Kralova, Renata, Kervitzer, Jan, Vasakova, Martina

“…Pirfenidone, an antifibrotic drug, slows-down the disease progression in idiopathic pulmonary fibrosis (IPF) over 12 months, however limited data on the…”
Get full text

Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial Lung Diseases by Sterclova, Martina, Doubkova, Martina, Sykorova, Lubica, Bartos, Vladimir, Zurkova, Monika, Lostakova, Vladimira, Mokosova, Radka, Plackova, Martina, Lacina, Ladislav, Cimrova, Michaela, Bittenglova, Radka, Lisa, Pavlina, Musilova, Pavla, Dolezal, Daniel, Psikalova, Jana, Ovesna, Petra, Koziar Vasakova, Martina

“…There are limited data on referral rates and the number of patients with idiopathic pulmonary fibrosis (IPF) who are eligible for lung transplantation. The aim…”
Get full text

DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study by Doubkova, Martina, Kriegova, Eva, Littnerova, Simona, Schneiderova, Petra, Sterclova, Martina, Bartos, Vladimir, Plackova, Martina, Zurkova, Monika, Bittenglova, Radka, Lostaková, Vladimira, Siskova, Lenka, Lisa, Pavlina, Suldova, Hana, Doubek, Michael, Psikalova, Jana, Snizek, Tomas, Musilova, Pavlina, Vasakova, Martina

“…Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of…”
Get full text

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study by Jovanovic, Dragana M, Šterclová, Martina, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Müller, Veronika, Hájková, Marta, Studnicka, Michael, Tekavec-Trkanjec, Jasna, Littnerová, Simona, Vašáková, Martina

“…Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple comorbidities, which may influence survival but go under-recognised in clinical…”
Get full text

Diagnostics of cystic fibrosis in adults by Fila, Libor, Grandcourtová, Alžběta, Bartáková, Lucie Valentová, Antušová, Zuzana, Pokojová, Eva, Herout, Vladimír, Jakubec, Petr, Bittenglová, Radka, Marel, Miloslav

“…There is an increasing number of cystic fibrosis (CF) patients with the diagnosis established in adulthood worldwide. To give an overview of our experience…”
Get more information

Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry by Doubková, Martina, Uher, Michal, Bartoš, Vladimír, Šterclová, Martina, Lacina, Ladislav, Lošťáková, Vladimíra, Binková, Ilona, Plačková, Martina, Žurková, Monika, Bittenglová, Radka, Pšikalová, Jana, Šišková, Lenka, Lisá, Pavlína, Petřík, František, Polák, Jaroslav, Řihák, Vladimír, Skřičková, Jana, Vašáková, Martina

“…Idiopathic pulmonary fibrosis (IPF) is a rare, progressive and usually fatal form of idiopathic interstitial pneumonia. IPF is characterized by failure of…”
Get more information

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study by Maher, Toby M, Stowasser, Susanne, Nishioka, Yasuhiko, White, Eric S, Cottin, Vincent, Noth, Imre, Selman, Moisés, Rohr, Klaus B, Michael, Andreas, Ittrich, Carina, Diefenbach, Claudia, Jenkins, R Gisli, Glaspole, Ian, Holmes, Mark, Troy, Lauren, Bondue, Benjamin, Dahlqvist, Caroline, Louis, Renaud, Van Meerbeeck, Jan, Wuyts, Wim, Bittenglova, Radka, Kolek, Vitezslav, Pauk, Norbert, Reiterer, Pavel, Sterclova, Martina, Mäkitaro, Riitta, Myllärniemi, Marjukka, Purokivi, Minna, Rantala, Terhi, Cottin, Vincent, Couturaud, Francis, Israel-Biet, Dominique, Jouneau, Stéphane, Kessler, Romain, Lebargy, François, Marchand-Adam, Sylvain, Bollmann, Tom, Günther, Andreas, Hammerl, Peter, Kirschner, Joachim, Kirsten, Anne-Marie, Kreuter, Michael, Neurohr, Claus, Prasse, Antje, Schönfeld, Nicolas, Wiewrodt, Rainer, Attila, Somfay, Balazs, Medgyasszay, Csanky, Eszter, Losonczy, György, Hayashi, Hiroki, Homma, Sakae, Inoue, Yoshikazu, Izumi, Shinyu, Kitamura, Hideya, Nishioka, Yasuhiko, Nishiyama, Osamu, Ogura, Takashi, Okamoto, Masaki, Saito, Takefumi, Taniguchi, Hiroyuki, Zaizen, Yoshiaki, Filipowska, Marzena, Jarzemska, Agnieszka, Pierzchala, Wladyslaw, Piotrowski, Wojciech, Sladek, Krzysztof, Trawinska, Ewa, Kim, Young Whan, Park, Jong Sun, Song, Jin Woo, Aburto, Myriam, Castillo Villegas, Diego, Echave-Sustaeta, José María, Garcia Fadul, Christian, Herrera, Susana, Moises, Jorge, Molina-Molina, María, Moreno, Amalia, Nieto, Asunción, Rodríguez Nieto, María Jesús, Rodriguez-Portal, José Antonio, Safont, Belen, Sellares, Jacobo, Valenzuela, Claudia, Adamali, Huzaifa, Chaudhuri, Nazia, Gibbons, Michael, Hoyles, Rachel, Maher, Toby, Parfrey, Helen, Averill, Francis, Chambers, Steven, Ettinger, Neil, Giessel, Glenn, Jones, Lisa M, Kaye, Mitchell G, Oelberg, David, Westerman, Jan H, Zoz, Donald

“…A hallmark of idiopathic pulmonary fibrosis is the excess accumulation of extracellular matrix in the lungs. Degradation of extracellular matrix generates…”
Get full text

Use of pepsin detection to identify airways reflux in a range of pulmonary diseases by Strugala, Vicki, Dettmar, Peter W, Bittenglova, Radka, Fremundova, Lucie, Peŝek, Milos

Get more information

rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study by Martina Doubkova, Eva Kriegova, Simona Littnerova, Petra Schneiderova, Martina Sterclova, Vladimir Bartos, Martina Plackova, Monika Zurkova, Radka Bittenglova, Vladimira Lostaková, Lenka Siskova, Pavlina Lisa, Hana Suldova, Michael Doubek, Jana Psikalova, Tomas Snizek, Pavlina Musilova, Martina Vasakova

“…Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of…”
Get full text

P38. Extraesophageal reflux disease and lung cancer by Pesek, Milos, Terezie, Turkova-Sedlackova, Radka, Bittenglova, Lucie, Fremundova

Get full text